Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li Di

Showing results (251-260 of 293) with videos related to

Pageof 30
Sort By:
Journal of Neurology|September 8, 2025
Factors associated with early response to efgartigimod in patients with generalized myasthenia gravis: a multicenter retrospective observational studyWenjia Zhu, Yuping Chen, Cong Tian, et al.
Molecular Cancer|May 1, 2025
Multi‑omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinomaBing Liu, Wei Tao, Xuantong Zhou, et al.
Journal of Medical Genetics|November 3, 2023
Non-coding CGG repeat expansion in <i>LOC642361/NUTM2B-AS1</i> is associated with a phenotype of oculopharyngodistal myopathyXinyu Gu, Jiaxi Yu, Kexin Jiao, et al.
Journal of Medicinal Chemistry|January 30, 2009
Discovery of (2S,4R)-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid hydrochloride (GAP-134)13, an orally active small molecule gap-junction modifier for the treatment of atrial fibrillationJohn A Butera, Bjarne Due Larsen, James K Hennan, et al.
Stem Cells and Development|July 28, 2016
Induced Pluripotent Stem Cell Differentiation and Three-Dimensional Tissue Formation Attenuate Clonal Epigenetic Differences in TrichohyalinAnastasia Petrova, Antonio Capalbo, Laureen Jacquet, et al.
Journal of Pharmaceutical Sciences|September 21, 2017
Industry Perspective on Contemporary Protein-Binding Methodologies: Considerations for Regulatory Drug-Drug Interaction and Related Guidelines on Highly Bound DrugsLi Di, Christopher Breen, Rob Chambers, et al.
Journal of Medicinal Chemistry|August 20, 2010
Discovery of 2-[1-(4-chlorophenyl)cyclopropyl]-3-hydroxy-8-(trifluoromethyl)quinoline-4-carboxylic acid (PSI-421), a P-selectin inhibitor with improved pharmacokinetic properties and oral efficacy in models of vascular injuryAdrian Huang, Alessandro Moretto, Kristin Janz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 2, 2022
<b>Transporter-Enzyme Interplay in the Pharmacokinetics of PF-06835919, A First-in-class Ketohexokinase Inhibitor for Metabolic Disorders and Non-alcoholic Fatty Liver Disease</b>Yan Weng, Kari R Fonseca, Yi-An Bi, et al.
CNS Neuroscience & Therapeutics|February 20, 2025
Clinical Features of Glutamic Acid Decarboxylase-65 Neurological Autoimmunity: A Case Series From ChinaZhandong Qiu, Fang Xu, Mengyao Zhang, et al.
Pharmaceutical Research|April 12, 2022
Unbound Brain-to-Plasma Partition Coefficient, K<sub>p,uu,brain</sub>-a Game Changing Parameter for CNS Drug Discovery and DevelopmentIrena Loryan, Andreas Reichel, Bo Feng, et al.
Pageof 30

Showing results (251-260 of 293) with videos related to

Sort By:
Pageof 30
Journal of Neurology|September 8, 2025
Factors associated with early response to efgartigimod in patients with generalized myasthenia gravis: a multicenter retrospective observational studyWenjia Zhu, Yuping Chen, Cong Tian, et al.
Molecular Cancer|May 1, 2025
Multi‑omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinomaBing Liu, Wei Tao, Xuantong Zhou, et al.
Journal of Medical Genetics|November 3, 2023
Non-coding CGG repeat expansion in <i>LOC642361/NUTM2B-AS1</i> is associated with a phenotype of oculopharyngodistal myopathyXinyu Gu, Jiaxi Yu, Kexin Jiao, et al.
Journal of Medicinal Chemistry|January 30, 2009
Discovery of (2S,4R)-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid hydrochloride (GAP-134)13, an orally active small molecule gap-junction modifier for the treatment of atrial fibrillationJohn A Butera, Bjarne Due Larsen, James K Hennan, et al.
Stem Cells and Development|July 28, 2016
Induced Pluripotent Stem Cell Differentiation and Three-Dimensional Tissue Formation Attenuate Clonal Epigenetic Differences in TrichohyalinAnastasia Petrova, Antonio Capalbo, Laureen Jacquet, et al.
Journal of Pharmaceutical Sciences|September 21, 2017
Industry Perspective on Contemporary Protein-Binding Methodologies: Considerations for Regulatory Drug-Drug Interaction and Related Guidelines on Highly Bound DrugsLi Di, Christopher Breen, Rob Chambers, et al.
Journal of Medicinal Chemistry|August 20, 2010
Discovery of 2-[1-(4-chlorophenyl)cyclopropyl]-3-hydroxy-8-(trifluoromethyl)quinoline-4-carboxylic acid (PSI-421), a P-selectin inhibitor with improved pharmacokinetic properties and oral efficacy in models of vascular injuryAdrian Huang, Alessandro Moretto, Kristin Janz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 2, 2022
<b>Transporter-Enzyme Interplay in the Pharmacokinetics of PF-06835919, A First-in-class Ketohexokinase Inhibitor for Metabolic Disorders and Non-alcoholic Fatty Liver Disease</b>Yan Weng, Kari R Fonseca, Yi-An Bi, et al.
CNS Neuroscience & Therapeutics|February 20, 2025
Clinical Features of Glutamic Acid Decarboxylase-65 Neurological Autoimmunity: A Case Series From ChinaZhandong Qiu, Fang Xu, Mengyao Zhang, et al.
Pharmaceutical Research|April 12, 2022
Unbound Brain-to-Plasma Partition Coefficient, K<sub>p,uu,brain</sub>-a Game Changing Parameter for CNS Drug Discovery and DevelopmentIrena Loryan, Andreas Reichel, Bo Feng, et al.
Pageof 30